Insider · CIK 0001810930
Yvonne Linney
Files at BNGO (Bionano Genomics, Inc.). First filing -, latest -.
In brief
Yvonne Linney files SEC Form 4 as director at BNGO (Bionano Genomics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Yvonne Linney has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 14, 2026 | BNGO Bionano Genomics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +9,149 | $0.00 | $0 | 9,149 | May 14, 2026 |
| Jun 11, 2025 | BNGO Bionano Genomics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +2,775 | $0.00 | $0 | 2,775 | Jun 12, 2025 |
| Jun 18, 2024 | BNGO Bionano Genomics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +30,000 | $0.00 | $0 | 30,000 | Jun 20, 2024 |
Questions about Yvonne Linney
Answered from the filings on this page, as of the latest one.
Is Yvonne Linney buying or selling?
Yvonne Linney has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Yvonne Linney's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Yvonne Linney has 0.
Where does Yvonne Linney file Form 4?
Yvonne Linney has filed Form 4 at BNGO (Bionano Genomics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.